COPDDry powder inhalerFluticasone propionateSalmeterolPurposeThe purpose of this review is to discuss the development of Wixela Inhub, a generic equivalent of Advair Diskus, a fixed-dose combination of fluticasone propionate/salmeterol powder for oral inhalation for patients with asthma whose symptoms are...
Therefore, it is imperative for asthmatics to keep asthma medications and asthma inhalers with them all the time. In the Asthma category, you will find life-saving medications such as Generic Advair, Salbutamol, and Generic Symbicort. These asthma inhalers help treat, prevent, and control an...
In China, industrial air pollution, urbanization, smoking, and increased population longevity have been cited as contributing to the prevalence of asthma and COPD [8]. The use of inhaled corticosteroids is gaining broader public acceptance, and pressurized metered dose inhalers (pMDIs) with salbutamo...
Will Downie, Chief Executive Officer of Vectura, said “This is excellent news for Vectura and for people living with asthma and COPD in the US. Approval of this high quality substitutable generic product for Advair Diskus validates Vectura’s rare, industry-leading development capabili...
“This is excellent news for Vectura and for people living with asthma and COPD in the US. Approval of this high quality substitutable generic product for Advair Diskus® validates Vectura’s rare, industry-leading development capabilities and the strong partnership we ...
"Today's approval of the first generic drug product for one of the most commonly prescribed asthma and COPD inhalers in the U.S. is part of our longstanding commitment to advance access to lower cost, high quality generic alternatives," said Janet Woodcock, MD, director of the FDA’s Cent...
Food and Drug Administration (FDA) approved the first generic maintenance inhaler for asthma and chronic obstructive pulmonary disease (COPD). The inhaler, Wixela Inhub (fluticasone–salmeterol; Viatris), is a substitutable version of the dry powder inhaler Advair Diskus (fluticasone–salmetero...
(HealthDay)—The first generic version of the widely used Advair Diskus inhaler for asthma and chronic obstructive pulmonary disease (COPD) has won U.S. Food and Drug Administration approval. This approval "is part of our longstanding commitment to advance access to lower cost, high-quality gene...
In 2019, the U.S. Food and Drug Administration (FDA) approved the first generic maintenance inhaler for asthma and COPD. The inhaler, Wixela Inhub (fluticasone–salmeterol; Viatris), is a substitutable version of the dry powder inhaler Advair Diskus (fluticasone–salmeterol; GlaxoSmithKline). ...